Status:
UNKNOWN
Pancreatic Stone Protein (PSP) in Pregnant Women
Lead Sponsor:
Nicole Ochsenbein
Collaborating Sponsors:
University of Zurich
Conditions:
Pregnancy
HELLP Syndrome
Eligibility:
FEMALE
18+ years
Brief Summary
This prospective, single centred cohort study evaluates the physiological course of the potentially novel biomarker PSP in pregnant women as well as its predictive role in the development of inflammat...
Detailed Description
Pregnant women feature a complex immunological condition caused by pregnancy itself and hence women present with an increased susceptibility to some infectious and non-infectious inflammatory diseases...
Eligibility Criteria
Inclusion
- Age \> 18 years
- Healthy women with single pregnancy
- Women with PPROM, AIS, preeclampsia, or HELLP syndrome
- Patients able to provide informed consent
Exclusion
- Viral (hepatitis B virus, hepatitis C virus, human immunodeficiency virus) or confirmed bacterial infections
Key Trial Info
Start Date :
September 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2019
Estimated Enrollment :
486 Patients enrolled
Trial Details
Trial ID
NCT02247297
Start Date
September 1 2014
End Date
September 1 2019
Last Update
November 26 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Zurich
Zurich, Switzerland, 8091